series-c-plus
Stage
1
Investors
About
MycoMedica Life Sciences is a biopharmaceutical company developing psilocybin-based psychedelic medicines for mental health and neurodegenerative disorders, focusing on clinical trials for conditions such as Premenstrual Dysphoric Disorder, OCD, and Parkinson's Disease.
Explore MycoMedica Life Sciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.